Lyell Immunopharma Stock Target Price and Analyst Consensus
| LYEL Stock | USD 2.36 0.04 1.67% |
The current analyst and expert consensus on Lyell Immunopharma is Buy, with only one strong buy opinion. The current projected Lyell Immunopharma target price consensus is 7.00 with 4 analyst opinions. The most common way Lyell Immunopharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Lyell Immunopharma executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Lyell Immunopharma. We encourage you to use your own analysis of Lyell Immunopharma to validate this buy or sell advice. Lyell Immunopharma buy-or-sell recommendation module provides average expert sentiment on the projected Lyell Immunopharma target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Lyell Immunopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.
Lowest Forecast 6.37 | Highest Forecast 7.77 | Target Price 7 |
Lyell |
It's important to approach Lyell Immunopharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Lyell Immunopharma Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Lyell target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Lyell Immunopharma's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Buy |
Most Lyell analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Lyell stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Lyell Immunopharma, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationLyell Immunopharma Target Price Projection
Lyell Immunopharma's current and average target prices are 2.36 and 7.00, respectively. The current price of Lyell Immunopharma is the price at which Lyell Immunopharma is currently trading. On the other hand, Lyell Immunopharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Lyell Immunopharma Market Quote on 6th of May 2024
Target Price
Analyst Consensus On Lyell Immunopharma Target Price
Lyell Immunopharma Analyst Ratings
Lyell Immunopharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Lyell Immunopharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Lyell Immunopharma's financials, market performance, and future outlook by experienced professionals. Lyell Immunopharma's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Lyell Immunopharma price targets
Lyell Immunopharma's stock target price is an estimate of its future price, usually made by analysts. Using Lyell Immunopharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at Lyell Immunopharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Lyell Immunopharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Lyell Immunopharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Lyell Immunopharma is a key component of Lyell Immunopharma valuation and have some predictive power on the future returns of a Lyell Immunopharma.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lyell Immunopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Video Games Invested over 500 shares | |
 | Business Services Invested over 100 shares | |
 | Baby Boomer Prospects Invested over 70 shares | |
 | Automobiles and Trucks Invested over 60 shares | |
 | Cash Cows Invested few shares | |
Check out Macroaxis Advice on Lyell Immunopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.Note that the Lyell Immunopharma information on this page should be used as a complementary analysis to other Lyell Immunopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Lyell Stock analysis
When running Lyell Immunopharma's price analysis, check to measure Lyell Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lyell Immunopharma is operating at the current time. Most of Lyell Immunopharma's value examination focuses on studying past and present price action to predict the probability of Lyell Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lyell Immunopharma's price. Additionally, you may evaluate how the addition of Lyell Immunopharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
The data published in Lyell Immunopharma's official financial statements usually reflect Lyell Immunopharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Lyell Immunopharma. For example, before you start analyzing numbers published by Lyell accountants, it's critical to develop an understanding of what Lyell Immunopharma's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Lyell Immunopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lyell Immunopharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Lyell Immunopharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lyell Immunopharma. Please utilize our Beneish M Score to check the likelihood of Lyell Immunopharma's management manipulating its earnings.